PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 62.62 -0.3 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.92 | 52 Week High | $35.40 | |||
| Open | $63.14 | 52 Week Low | $4.03 | |||
| Day High | $63.74 | P/E | 6.66 | |||
| Day Low | $62.41 | EPS | $9.40 | |||
| Volume | 944,163 | |||||
